Who Owns Biodexa Pharmaceuticals Plc (BDRX)?Hedge Fund & Institutional Holders
Institutional Holders
9
as of Q4 2025
Total Institutional Value
$22.7T
% of Float Held
—
QoQ Change in Holders
+5 / -0
Price History
BDRX — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | New Position | +100K | +$227K |
| HRT FINANCIAL LP | New Position | +11K | +$0 |
| SABBY MANAGEMENT, LLC | New Position | +191K | +$0 |
| SBI Securities Co., Ltd. | New Position | +101 | +$0 |
| Hilton Head Capital Partners, LLC | New Position | +30 | +$0 |
| RHUMBLINE ADVISERS | Increased | +19 | +$-32K |
| GAMMA Investing LLC | Increased | +425 | +$-9.0M |
BDRX — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| UBS Group AG | Decreased | -5K | -$46.0M |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 100,000 | $227K | 0.00% | Share |
| 2 | GAMMA Investing LLC | 1,777 | $4K | 0.00% | Share |
| 3 | UBS Group AG | 1,917 | $4K | 0.00% | Share |
| 4 | SABBY MANAGEMENT, LLC | 190,658 | $0 | 0.00% | Share |
| 5 | Hilton Head Capital Partners, LLC | 30 | $0 | 0.00% | Share |
| 6 | UBS Group AG | 183 | $0 | 0.00% | Share |
| 7 | SBI Securities Co., Ltd. | 101 | $0 | 0.00% | Share |
| 8 | HRT FINANCIAL LP | 10,583 | $0 | 0.00% | Share |
| 9 | RHUMBLINE ADVISERS | 24 | $0 | 0.00% | Share |
BDRX Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 8 | $235K | +5 |
| Q3 2025 | 3 | $55.1M | -2 |
| Q2 2025 | 5 | $17.0M | -1 |
| Q1 2025 | 6 | $27.7M | +1 |
| Q4 2024 | 5 | $28.7M | -2 |
| Q3 2024 | 7 | $76.2B | -4 |
| Q2 2024 | 11 | $66.7B | +5 |
| Q1 2024 | 6 | $12.5B | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 9 institutional investors hold BDRX (Biodexa Pharmaceuticals Plc). The largest holder is ARMISTICE CAPITAL, LLC with $227K in shares. This quarter, 5 institutions opened new positions and 0 closed their positions.
Frequently Asked Questions
How many hedge funds own BDRX?
As of Q4 2025, 9 institutional investors report holding BDRX (Biodexa Pharmaceuticals Plc) in their 13F filings.
Who is the largest institutional holder of BDRX?
The largest institutional holder of BDRX is ARMISTICE CAPITAL, LLC with $227K in shares.
Is institutional ownership of BDRX increasing or decreasing?
This quarter, 5 institutions opened new positions in BDRX and 0 closed their positions.